As per MRFR analysis, the Animal Gastroesophageal Reflux Disease Market Size was estimated at 1.88 (USD Billion) in 2022. The Animal Gastroesophageal Reflux Disease Market is expected to grow from 1.98 (USD Billion) in 2023 to 3.2 (USD Billion) by 2032. The Animal Gastroesophageal Reflux Disease Market CAGR (growth rate) is expected to be around 5.48% during the forecast period (2024 - 2032).
Key Animal Gastroesophageal Reflux Disease Market Trends Highlighted
Advances in veterinary care, growing pet ownership, and growing awareness of animal health issues are the main factors driving the animal gastroesophageal reflux disease (GERD) market. Additionally, the industry is expanding due to the rising popularity of luxury pet food and the accessibility of specialist healthcare services.
The creation of cutting-edge therapeutic alternatives, like minimally invasive operations and cutting-edge drugs, presents new prospects in the animal GERD market. Furthermore, substantial opportunities for market growth are anticipated to be created by the expansion of pet insurance coverage and the rising usage of telemedicine in veterinarian care.
Recent developments in the animal GERD market include the increased incidence of obesity and nutritional imbalances in pets, both of which are factors in the development of GERD. In addition, the market dynamics are being shaped by the growing accessibility of over-the-counter drugs and home treatments for GERD.
Additionally gaining traction is the use of cutting-edge diagnostic methods like pH monitoring and endoscopy, which allow for the early identification and successful treatment of GERD in animals.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Animal Gastroesophageal Reflux Disease Market Drivers
Increased Prevalence of Gastroesophageal Reflux Disease in Animals
Gastroesophageal reflux disease (GERD) is a common condition in animals, characterized by the backflow of stomach contents into the esophagus. This can cause a range of symptoms, including vomiting, regurgitation, coughing, and difficulty swallowing.
The prevalence of GERD is increasing in animals, due to a number of factors, including obesity, dietary changes, and the use of certain medications. This is driving the demand for effective treatments for GERD in animals.
Rising Awareness of GERD in Animals
Veterinarians and pet owners are becoming increasingly aware of GERD in animals. This is due to a number of factors, including the availability of more information about the condition, the development of new diagnostic techniques, and the increasing use of endoscopy to visualize the esophagus.
This increased awareness is leading to more animals being diagnosed with GERD and treated for the condition.
Development of New and Improved Treatments for GERD in Animals
There is a growing demand for new and improved treatments for GERD in animals. This is due to the increasing prevalence of the condition, the rising awareness of GERD, and the limitations of current treatments.
A number of new and improved treatments are being developed, including medications, surgical procedures, and lifestyle changes.
These new treatments are expected to provide more effective relief from GERD symptoms and improve the quality of life for animals with the condition.
Animal Gastroesophageal Reflux Disease Market Segment Insights:
Animal Gastroesophageal Reflux Disease Market Disease Severity Insights
The Animal Gastroesophageal Reflux Disease Market is segmented by disease severity into Mild, Moderate, and Severe. Among these segments, the Moderate severity segment held the largest share of the market in 2023 and is projected to continue its dominance throughout the forecast period.
The high prevalence of Moderate severity GERD in companion animals, particularly dogs and cats, is a major factor driving the growth of this segment. Moderate severity GERD is characterized by symptoms such as occasional vomiting, regurgitation, and heartburn, which are common in pets with underlying gastrointestinal issues.
The increasing adoption of companion animals and the growing awareness of pet health and well-being are also contributing to market growth. The Mild severity segment is expected to witness steady growth over the forecast period.
Mild severity GERD is characterized by infrequent symptoms and is often managed with lifestyle modifications and over-the-counter medications. The increasing availability of effective and affordable treatment options for Mild severity GERD is expected to drive the growth of this segment. The Severe severity segment is estimated to grow at a moderate pace during the forecast period.
Severe severity GERD is characterized by frequent and severe symptoms, including esophageal ulceration, bleeding, and stricture formation. The high cost of treatment and the need for specialized care for animals with Severe severity GERD are factors that may limit the growth of this segment.
Overall, the Animal Gastroesophageal Reflux Disease Market is poised for significant growth in the coming years, driven by the rising prevalence of GERD in companion animals and the increasing adoption of pets worldwide.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Animal Gastroesophageal Reflux Disease Market Animal Type Insights
The Animal Gastroesophageal Reflux Disease Market segmentation by Animal Type comprises Cats, Dogs, Horses, and Other Animals. Among these, the Dogs segment held the largest market share in 2023, accounting for around 42.5% of the Animal Gastroesophageal Reflux Disease Market revenue.
The large market share of the Dogs segment can be attributed to factors such as the high prevalence of gastroesophageal reflux disease in dogs, coupled with the growing adoption of dogs as companion animals. The Cats segment is expected to witness the fastest growth during the forecast period, owing to the increasing awareness about animal health and the rising disposable income of pet owners.
The Other Animals segment, which includes animals such as rabbits, ferrets, and birds, is also expected to contribute significantly to the growth of the market.
Animal Gastroesophageal Reflux Disease Market Treatment Type Insights
The Animal Gastroesophageal Reflux Disease Market is segmented based on Treatment Type into Medications, Surgery, and Lifestyle Modifications. Medications dominated the Animal Gastroesophageal Reflux Disease Market, accounting for a major revenue share in 2023.
The growth of this segment can be attributed to the increasing prevalence of gastroesophageal reflux disease (GERD) in animals, rising awareness about the condition, and the efficacy of medications in managing GERD symptoms. Surgery is another significant segment in the Animal Gastroesophageal Reflux Disease Market, with steady growth expected over the forecast period.
Surgical interventions are primarily recommended for severe cases of GERD that do not respond to medications. Advancements in surgical techniques and the growing expertise of veterinary surgeons are driving the demand for surgical treatments.
Lifestyle modifications, such as dietary changes and weight management, play a crucial role in managing animal GERD. The lifestyle modifications segment is expected to witness moderate growth, driven by increasing awareness about the importance of preventive measures and the growing adoption of holistic approaches to animal healthcare.
Animal Gastroesophageal Reflux Disease Market Diagnostics Insights
Diagnostics plays a crucial role in identifying and confirming Animal Gastroesophageal Reflux Disease (GERD) in animals. Esophageal pH Monitoring is a gold standard diagnostic technique that measures the acidity levels in the esophagus over a 24-hour period. It helps detect abnormal acid reflux patterns and assess the severity of GERD.
Upper Endoscopy involves inserting a thin, flexible tube with a camera into the esophagus to visualize the esophageal lining, identify lesions, and obtain biopsies for further analysis.
Barium Swallow is a radiographic imaging technique where the animal ingests a barium-based contrast agent, allowing visualization of the esophagus and stomach to detect anatomical abnormalities and motility disorders associated with GERD.
The Animal Gastroesophageal Reflux Disease Market for Diagnostics is anticipated to grow significantly in the coming years. The increasing prevalence of GERD in companion animals, advancements in diagnostic technologies, and rising awareness among pet owners are driving market growth.
Technological advancements, such as wireless pH monitoring systems and high-resolution endoscopes, enhance diagnostic accuracy and provide more detailed insights into esophageal function. Moreover, the growing adoption of pet insurance and increasing disposable income contribute to the market's expansion.
Animal Gastroesophageal Reflux Disease Market Regional Insights
North America held the largest share of the Animal Gastroesophageal Reflux Disease Market revenue in 2023, owing to the increasing prevalence of gastroesophageal reflux disease (GERD) in companion animals, rising pet ownership rates, and growing awareness of animal health.
The market in Europe is anticipated to hold a significant share, driven by factors such as the presence of a large number of veterinary clinics, increasing pet insurance penetration, and growing demand for advanced veterinary care.
APAC is projected to witness the fastest growth over the forecast period due to factors such as the rising disposable income, increasing awareness of animal health, and growing pet population in countries like China and India.
South America and MEA are expected to hold a relatively smaller share of the market, but they are expected to exhibit steady growth over the forecast period.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Animal Gastroesophageal Reflux Disease Market Key Players and Competitive Insights:
Major players in the Animal Gastroesophageal Reflux Disease Market are constantly striving to develop innovative products and solutions to cater to the evolving needs of customers. Leading Animal Gastroesophageal Reflux Disease Market players are investing heavily in research and development activities to enhance their product portfolios and gain a competitive edge in the market.
The Animal Gastroesophageal Reflux Disease Market development is driven by factors such as the increasing prevalence of animal gastroesophageal reflux disease, rising awareness about animal health and well-being, and growing demand for advanced diagnostic and treatment options.
The Animal Gastroesophageal Reflux Disease Market Competitive Landscape is expected to remain highly competitive in the coming years, with key players focusing on product innovation, strategic partnerships, and geographical expansion to strengthen their market positions.
Zoetis Inc., a leader in animal health, holds a significant position in the Animal Gastroesophageal Reflux Disease Market. The company offers a range of products for the diagnosis and treatment of animal gastroesophageal reflux disease, including medications, diagnostic tests, and surgical devices.
Zoetis Inc. is committed to providing innovative solutions to improve animal health and well-being, and it continues to invest in research and development to enhance its product offerings. The company's strong brand reputation, extensive distribution network, and commitment to customer satisfaction contribute to its leading position in the Animal Gastroesophageal Reflux Disease Market.
Merck & Co., Inc., another prominent player in the Animal Gastroesophageal Reflux Disease Market, offers a comprehensive portfolio of products and services for the diagnosis and treatment of animal gastroesophageal reflux disease.
The company's product offerings include medications, diagnostic tests, and surgical devices, and it is known for its focus on developing innovative solutions that improve animal health outcomes. Merck & Co., Inc. has a strong presence and a wide distribution network, which enables it to reach a large customer base.
The company's commitment to research and development, combined with its extensive product portfolio and reach, positions it as a key competitor in the Animal Gastroesophageal Reflux Disease Market.
Key Companies in the Animal Gastroesophageal Reflux Disease Market Include:
Animal Gastroesophageal Reflux Disease Market Developments
The rising pet ownership, increasing prevalence of obesity in companion animals, and growing awareness of GERD in veterinary medicine drive market growth. Advancements in diagnostic techniques and the development of novel therapeutic options further contribute to market expansion.
Key industry players are investing in research and development to enhance treatment efficacy and reduce side effects. Strategic collaborations and partnerships among market participants aim to expand product portfolios and strengthen market presence.
Animal Gastroesophageal Reflux Disease Market Segmentation Insights
| Report Attribute/Metric | Details |
| Market Size 2022 | 1.88(USD Billion) |
| Market Size 2023 | 1.98(USD Billion) |
| Market Size 2032 | 3.2(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 5.48% (2024 - 2032) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2023 |
| Market Forecast Period | 2024 - 2032 |
| Historical Data | 2019 - 2023 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Merck Co., Zoetis, Heska Corporation, Neogen Corporation, Dechra Pharmaceuticals, AniCura, Synbiotics Corporation, Vetoquinol SA, Boehringer Ingelheim, IDEXX Laboratories, Bayer AG, Virbac, Ceva Animal Health, Elanco Animal Health |
| Segments Covered | Disease Severity, Animal Type, Treatment Type, Diagnostics, Regional |
| Key Market Opportunities | Rising pet ownership Increasing prevalence of GERD in animals Growing awareness of animal health Advancements in diagnostics and therapeutics Expansion of veterinary infrastructure |
| Key Market Dynamics | Increased pet ownership Growing prevalence of GERD in companion animals Rising awareness of animal health Technological advancements in veterinary medicine Expanding pet insurance coverage |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Animal Gastroesophageal Reflux Disease Market reached a valuation of 1.98 billion USD in 2023.
The market is projected to reach a valuation of 3.2 billion USD by 2032.
The market is expected to expand at a CAGR of 5.48% during the forecast period.
North America is anticipated to dominate the market throughout the forecast period.
Rising pet ownership, increasing awareness of animal health, and advancements in veterinary medicine are driving market growth.
Treatment involves medications to reduce stomach acid production, protect the esophageal lining, and promote healing.
Prominent players include Zoetis, Merck Animal Health, and Elanco Animal Health.
Challenges include the high cost of treatment and the limited availability of specialized veterinary care in some regions.
Opportunities lie in the development of novel therapies, the expansion of veterinary services, and increasing pet insurance coverage.
Trends include the adoption of precision medicine, the use of telemedicine for remote consultations, and the growing popularity of pet health supplements.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
